ANASTROZOLE TABLETS

ANASTROZOLE TABLETS was reported 21958 times

ANASTROZOLE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMAUROSIS FUGAX 224 0.2080
1 PERFORMANCE ENHANCING PRODUCT USE 20 0.2020
2 ENDOMETRIAL CANCER STAGE III 15 0.1899
3 PIK3CA-ACTIVATED MUTATION 48 0.1446
4 HUMAN RHINOVIRUS TEST POSITIVE 52 0.1394
5 PSEUDOCIRRHOSIS 45 0.1355
6 MUSCULOSKELETAL TOXICITY 22 0.1183
7 METASTASES TO BREAST 35 0.1054
8 CARBOHYDRATE ANTIGEN 15-3 INCREASED 77 0.1012
9 VIRAL TEST POSITIVE 36 0.0992
10 PLEURAL NEOPLASM 16 0.0970
11 CHEST WALL MASS 22 0.0846
12 PNEUMONIA HAEMOPHILUS 41 0.0844
13 METASTASES TO SPINAL CORD 16 0.0825
14 METASTASES TO CHEST WALL 28 0.0807
15 METASTASES TO ABDOMINAL WALL 16 0.0804
16 METASTASES TO THORAX 20 0.0791
17 SECONDARY HYPOGONADISM 25 0.0758
18 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 53 0.0754
19 METASTASES TO THE MEDIASTINUM 31 0.0752
20 PSEUDOCELLULITIS 16 0.0748
21 METASTASES TO PELVIS 40 0.0633
22 BREAST CANCER RECURRENT 195 0.0617
23 TUMOUR MARKER ABNORMAL 20 0.0604
24 HORMONE RECEPTOR POSITIVE BREAST CANCER 16 0.0588
25 SCAN ABNORMAL 20 0.0542
26 METASTASES TO OVARY 16 0.0502
27 METASTASES TO BONE 808 0.0492
28 URINARY TRACT DISORDER 204 0.0453
29 METASTASES TO SPINE 151 0.0449
30 HYPERPARATHYROIDISM PRIMARY 15 0.0412
31 INVASIVE LOBULAR BREAST CARCINOMA 21 0.0409
32 BREAST CANCER METASTATIC 417 0.0388
33 METASTASES TO PLEURA 39 0.0372
34 BLOOD ALBUMIN ABNORMAL 19 0.0365
35 HAIR DISORDER 280 0.0339
36 TUMOUR MARKER INCREASED 161 0.0335
37 METASTASES TO BONE MARROW 16 0.0320
38 HAEMORRHAGIC STROKE 246 0.0315
39 METASTASES TO LUNG 360 0.0311
40 TONSILLAR DISORDER 35 0.0311
41 FASCIITIS 20 0.0305
42 CENTRAL NERVOUS SYSTEM VASCULITIS 15 0.0294
43 TONGUE INJURY 27 0.0288
44 METASTASES TO LIVER 481 0.0273
45 METASTASES TO SKIN 28 0.0271
46 METASTASES TO LYMPH NODES 182 0.0269
47 INVASIVE DUCTAL BREAST CARCINOMA 72 0.0265
48 RETINAL TOXICITY 27 0.0262
49 DECREASED IMMUNE RESPONSIVENESS 257 0.0262
50 MADAROSIS 299 0.0257
51 HAIR COLOUR CHANGES 318 0.0255
52 TRIGGER FINGER 103 0.0252
53 AXILLARY MASS 26 0.0250
54 HAIR TEXTURE ABNORMAL 334 0.0249
55 PERITONEAL DISORDER 16 0.0247
56 ATROPHIC VULVOVAGINITIS 18 0.0246
57 BLOOD ALKALINE PHOSPHATASE ABNORMAL 22 0.0244
58 PSYCHOLOGICAL TRAUMA 204 0.0236
59 BONE LESION 85 0.0235
60 GLOMERULAR FILTRATION RATE INCREASED 19 0.0230
61 MAST CELL ACTIVATION SYNDROME 32 0.0228
62 INTRADUCTAL PROLIFERATIVE BREAST LESION 28 0.0224
63 MEAN CELL HAEMOGLOBIN INCREASED 37 0.0223
64 OVARIAN MASS 16 0.0217
65 VULVOVAGINAL DRYNESS 70 0.0216
66 OCULAR DISCOMFORT 243 0.0216
67 REFLUX GASTRITIS 26 0.0216
68 OSTEOLYSIS 43 0.0210
69 NASAL DISORDER 53 0.0199
70 TONGUE BITING 41 0.0199
71 MACROCYTOSIS 23 0.0198
72 PELVIC MASS 16 0.0198
73 METASTASIS 137 0.0192
74 OSTEOSCLEROSIS 30 0.0190
75 MALIGNANT PLEURAL EFFUSION 30 0.0178
76 OESTROGEN RECEPTOR ASSAY POSITIVE 20 0.0176
77 GENERALISED OEDEMA 213 0.0172
78 MESENTERIC VEIN THROMBOSIS 17 0.0171
79 HEAD DISCOMFORT 295 0.0166
80 BLOOD BILIRUBIN ABNORMAL 21 0.0164
81 GENE MUTATION 32 0.0162
82 SECOND PRIMARY MALIGNANCY 131 0.0157
83 EXCESSIVE EYE BLINKING 23 0.0156
84 SIALOADENITIS 21 0.0154
85 NAIL INFECTION 22 0.0153
86 RADIATION INJURY 16 0.0150
87 CYSTOID MACULAR OEDEMA 28 0.0148
88 ALANINE AMINOTRANSFERASE ABNORMAL 31 0.0147
89 BREAST DISCOMFORT 15 0.0145
90 DISCOURAGEMENT 34 0.0145
91 HEPATIC MASS 28 0.0145
92 VITILIGO 34 0.0145
93 MEAN CELL VOLUME INCREASED 37 0.0144
94 NEUTROPHIL COUNT ABNORMAL 39 0.0138
95 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 17 0.0136
96 METASTATIC NEOPLASM 58 0.0134
97 BREAST MASS 89 0.0132
98 BLOOD CALCIUM ABNORMAL 22 0.0132
99 LYMPHOEDEMA 90 0.0130
100 ASCITES 356 0.0121
101 SUPERINFECTION 18 0.0120
102 BREAST DISORDER 24 0.0118
103 ATYPICAL FEMUR FRACTURE 32 0.0113
104 HEPATIC LESION 49 0.0113
105 BICYTOPENIA 22 0.0112
106 ALTERED STATE OF CONSCIOUSNESS 238 0.0110
107 MENOPAUSAL SYMPTOMS 25 0.0107
108 POLYCYTHAEMIA 22 0.0107
109 RED CELL DISTRIBUTION WIDTH INCREASED 44 0.0106
110 MALIGNANT NEOPLASM PROGRESSION 1084 0.0106
111 NEOPLASM PROGRESSION 368 0.0106
112 INSULIN-LIKE GROWTH FACTOR INCREASED 15 0.0105
113 EJECTION FRACTION DECREASED 163 0.0105
114 PORTAL HYPERTENSION 32 0.0104
115 ALOPECIA AREATA 18 0.0103
116 PHOTOPHOBIA 192 0.0102
117 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 18 0.0101
118 METASTASES TO CENTRAL NERVOUS SYSTEM 130 0.0101
119 PRESYNCOPE 243 0.0100
120 CARCINOEMBRYONIC ANTIGEN INCREASED 19 0.0098
121 MASTECTOMY 17 0.0097
122 WHITE BLOOD CELL DISORDER 26 0.0097
123 HAEMATEMESIS 246 0.0097
124 DIPLOPIA 245 0.0094
125 BONE CANCER 41 0.0094
126 LYMPHADENOPATHY MEDIASTINAL 18 0.0094
127 CANCER PAIN 24 0.0094
128 SPINAL PAIN 109 0.0093
129 NAIL DISORDER 81 0.0092
130 SKIN ATROPHY 53 0.0092
131 BONE PAIN 536 0.0091
132 METASTASES TO PERITONEUM 23 0.0091
133 WHITE BLOOD CELL COUNT ABNORMAL 58 0.0091
134 POLYNEUROPATHY 107 0.0089
135 GINGIVAL RECESSION 17 0.0088
136 FOOD AVERSION 15 0.0088
137 DENGUE FEVER 20 0.0087
138 BREAST DISCHARGE 15 0.0086
139 NEOPLASM RECURRENCE 29 0.0085
140 MENOPAUSE 22 0.0085
141 MOUTH HAEMORRHAGE 62 0.0084
142 EOSINOPHIL COUNT DECREASED 20 0.0084
143 HEPATIC CYST 28 0.0082
144 OSTEONECROSIS OF JAW 203 0.0082
145 ONYCHOCLASIS 56 0.0081
146 BLOOD TESTOSTERONE INCREASED 17 0.0079
147 WHITE BLOOD CELL COUNT DECREASED 847 0.0078
148 BREAST PAIN 83 0.0078
149 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 19 0.0077
150 PATHOLOGICAL FRACTURE 39 0.0077
151 RED BLOOD CELL COUNT DECREASED 219 0.0077
152 BLOOD CREATININE ABNORMAL 26 0.0075
153 RADIATION PNEUMONITIS 16 0.0075
154 ALOPECIA 1468 0.0075
155 SKIN HYPERTROPHY 21 0.0075
156 FULL BLOOD COUNT ABNORMAL 79 0.0075
157 ACUTE LYMPHOCYTIC LEUKAEMIA 21 0.0074
158 VITREOUS DETACHMENT 16 0.0074
159 FULL BLOOD COUNT DECREASED 147 0.0073
160 HOT FLUSH 548 0.0073
161 TRICHORRHEXIS 20 0.0072
162 ADENOCARCINOMA 16 0.0071
163 BREAST CANCER 665 0.0071
164 OSTEOPENIA 108 0.0071
165 MOUTH SWELLING 41 0.0071
166 PULMONARY MASS 103 0.0069
167 RHINALGIA 19 0.0069
168 SENSITIVE SKIN 51 0.0069
169 PLANTAR FASCIITIS 23 0.0069
170 PULMONARY PAIN 20 0.0068
171 PUSTULE 16 0.0067
172 CARBOHYDRATE ANTIGEN 125 INCREASED 23 0.0067
173 OSTEITIS 17 0.0067
174 BREAST CANCER STAGE IV 19 0.0067
175 LEUKOPENIA 335 0.0067
176 BLINDNESS 271 0.0066
177 NEUTROPENIA 902 0.0066
178 POOR PERIPHERAL CIRCULATION 28 0.0066
179 IMPAIRED QUALITY OF LIFE 94 0.0065
180 HAEMATURIA 223 0.0065
181 HEPATOTOXICITY 144 0.0065
182 MUSCULOSKELETAL CHEST PAIN 99 0.0064
183 BONE DISORDER 116 0.0064
184 NAIL DISCOLOURATION 25 0.0064
185 CEREBRAL THROMBOSIS 18 0.0064
186 HAIR GROWTH ABNORMAL 44 0.0064
187 BREAST SWELLING 17 0.0063
188 HYPOVOLAEMIA 37 0.0063
189 NASAL DRYNESS 39 0.0062
190 NEOPLASM 71 0.0062
191 RECURRENT CANCER 25 0.0061
192 LUNG OPACITY 16 0.0061
193 ORGANISING PNEUMONIA 30 0.0060
194 PIGMENTATION DISORDER 37 0.0060
195 ABDOMINAL MASS 16 0.0060
196 DERMATOMYOSITIS 15 0.0059
197 NEUTROPHIL COUNT DECREASED 236 0.0058
198 GROWTH RETARDATION 17 0.0058
199 TINNITUS 265 0.0058
200 AUTOIMMUNE HEPATITIS 40 0.0057
201 EYE PAIN 323 0.0057
202 HYPERSENSITIVITY VASCULITIS 15 0.0057
203 HAEMOGLOBIN INCREASED 26 0.0057
204 LACRIMATION INCREASED 172 0.0057
205 CARDIO-RESPIRATORY ARREST 237 0.0057
206 SYNOVIAL CYST 26 0.0056
207 RHINITIS 45 0.0056
208 BRAIN FOG 87 0.0055
209 BREAST ENLARGEMENT 18 0.0055
210 CUTANEOUS VASCULITIS 20 0.0055
211 FEEDING DISORDER 110 0.0054
212 PANIC DISORDER 21 0.0054
213 PAPILLOEDEMA 24 0.0053
214 HAEMOGLOBIN ABNORMAL 34 0.0053
215 HIATUS HERNIA 68 0.0052
216 MONOCYTE COUNT INCREASED 19 0.0052
217 HYPOVENTILATION 17 0.0052
218 GINGIVAL SWELLING 23 0.0052
219 UTERINE LEIOMYOMA 38 0.0052
220 BLOOD PHOSPHORUS DECREASED 19 0.0052
221 FEELING OF DESPAIR 24 0.0051
222 BODY HEIGHT DECREASED 55 0.0051
223 TASTE DISORDER 104 0.0051
224 LEFT VENTRICULAR DYSFUNCTION 34 0.0051
225 CARPAL TUNNEL SYNDROME 71 0.0051
226 COMA 240 0.0050
227 APHTHOUS ULCER 39 0.0050
228 OVARIAN CANCER 46 0.0050
229 ORAL PAIN 111 0.0050
230 RHINITIS ALLERGIC 22 0.0049
231 FRACTURE 93 0.0049
232 PHLEBITIS 25 0.0049
233 DRY THROAT 49 0.0048
234 VEIN DISORDER 24 0.0048
235 GLOSSITIS 17 0.0048
236 NODULE 62 0.0047
237 THYROID MASS 18 0.0047
238 CARDIAC FAILURE ACUTE 31 0.0046
239 VAGINAL DISCHARGE 47 0.0046
240 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 30 0.0046
241 LYMPHOCYTE COUNT DECREASED 81 0.0046
242 MUCOSAL INFLAMMATION 118 0.0045
243 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 105 0.0045
244 AUTOIMMUNE THYROIDITIS 17 0.0045
245 HYPERCALCAEMIA 55 0.0044
246 HEPATIC PAIN 19 0.0044
247 TOOTH EXTRACTION 55 0.0044
248 CONCOMITANT DISEASE AGGRAVATED 27 0.0044
249 EATING DISORDER 93 0.0044
250 HOSPICE CARE 43 0.0043
251 JOINT STIFFNESS 113 0.0043
252 BREAST CANCER FEMALE 115 0.0043
253 NEURODERMATITIS 16 0.0043
254 PERIPHERAL SENSORY NEUROPATHY 25 0.0043
255 CARDIOTOXICITY 38 0.0043
256 TONGUE DISCOMFORT 18 0.0042
257 SPINAL DISORDER 40 0.0042
258 STOMATITIS 255 0.0042
259 MUSCULOSKELETAL DISCOMFORT 72 0.0042
260 NEUROPATHY PERIPHERAL 397 0.0042
261 IMMUNODEFICIENCY 62 0.0042
262 EAR DISORDER 19 0.0041
263 HAEMATOCRIT DECREASED 82 0.0041
264 SPINAL CORD COMPRESSION 16 0.0041
265 DISEASE PROGRESSION 486 0.0041
266 PAIN IN JAW 116 0.0041
267 TIBIA FRACTURE 19 0.0040
268 HAEMORRHOIDS 79 0.0040
269 GASTROINTESTINAL SOUNDS ABNORMAL 20 0.0040
270 ISCHAEMIC STROKE 72 0.0040
271 RENAL PAIN 42 0.0040
272 VULVOVAGINAL BURNING SENSATION 24 0.0039
273 LYMPHADENOPATHY 139 0.0039
274 ACUTE MYELOID LEUKAEMIA 61 0.0039
275 ARTHRALGIA 1621 0.0039
276 PNEUMONITIS 105 0.0039
277 DECREASED APPETITE 893 0.0038
278 EPIGASTRIC DISCOMFORT 15 0.0038
279 VITAMIN D DEFICIENCY 37 0.0038
280 BLOOD ALKALINE PHOSPHATASE INCREASED 93 0.0037
281 DYSLIPIDAEMIA 19 0.0037
282 MYALGIA 634 0.0037
283 PLEURAL EFFUSION 226 0.0037
284 TOOTHACHE 67 0.0037
285 CHOLESTASIS 71 0.0037
286 HEPATIC CYTOLYSIS 47 0.0037
287 SCAB 42 0.0037
288 PLATELET COUNT INCREASED 48 0.0037
289 RENAL FUNCTION TEST ABNORMAL 17 0.0037
290 JAW DISORDER 20 0.0036
291 TRICUSPID VALVE INCOMPETENCE 29 0.0036
292 TRANSAMINASES INCREASED 81 0.0036
293 TACHYCARDIA 323 0.0036
294 DRUG-INDUCED LIVER INJURY 114 0.0036
295 BLOOD COUNT ABNORMAL 55 0.0036
296 FLANK PAIN 34 0.0036
297 VULVOVAGINAL DISCOMFORT 16 0.0036
298 HEPATIC STEATOSIS 67 0.0036
299 SKIN MASS 24 0.0036
300 OSTEOPOROSIS 147 0.0036
301 COMPRESSION FRACTURE 19 0.0035
302 SLUGGISHNESS 36 0.0035
303 VASCULAR DEVICE INFECTION 16 0.0035
304 VITAMIN D DECREASED 30 0.0035
305 MASS 49 0.0035
306 TENDONITIS 54 0.0035
307 HORMONE LEVEL ABNORMAL 17 0.0035
308 LIVER FUNCTION TEST INCREASED 74 0.0034
309 DEPRESSED MOOD 182 0.0034
310 ALANINE AMINOTRANSFERASE INCREASED 210 0.0034
311 ABNORMAL FAECES 28 0.0034
312 BLOOD TEST ABNORMAL 48 0.0034
313 MENISCUS INJURY 21 0.0034
314 BLOOD LACTATE DEHYDROGENASE INCREASED 54 0.0034
315 GASTROINTESTINAL MOTILITY DISORDER 18 0.0034
316 CHILLS 393 0.0033
317 ASPARTATE AMINOTRANSFERASE INCREASED 178 0.0033
318 DRUG INTOLERANCE 321 0.0033
319 ARTERIOSCLEROSIS CORONARY ARTERY 22 0.0033
320 HYPERTHYROIDISM 48 0.0033
321 ENDOCARDITIS 17 0.0033
322 LIP DRY 30 0.0033
323 BLOOD CALCIUM DECREASED 37 0.0033
324 NEURALGIA 80 0.0033
325 CYTOPENIA 40 0.0033
326 HEPATITIS ACUTE 21 0.0032
327 LOWER LIMB FRACTURE 62 0.0032
328 MITRAL VALVE INCOMPETENCE 36 0.0032
329 SYNCOPE 318 0.0032
330 TOOTH FRACTURE 35 0.0032
331 COLITIS MICROSCOPIC 15 0.0032
332 FATIGUE 2457 0.0032
333 PLATELET COUNT DECREASED 335 0.0031
334 COUGH 881 0.0031
335 GASTROINTESTINAL TOXICITY 15 0.0031
336 OROPHARYNGEAL DISCOMFORT 28 0.0031
337 HAEMOGLOBIN DECREASED 316 0.0031
338 HYDRONEPHROSIS 23 0.0031
339 SKIN DISCOLOURATION 141 0.0031
340 URINE ODOUR ABNORMAL 18 0.0031
341 PAROSMIA 23 0.0030
342 AGEUSIA 76 0.0030
343 MOUTH ULCERATION 64 0.0030
344 NASAL DISCOMFORT 24 0.0030
345 SKIN TOXICITY 17 0.0030
346 PHOTOPSIA 19 0.0030
347 WOUND 84 0.0030
348 ELECTROCARDIOGRAM QT PROLONGED 108 0.0030
349 ORAL DISORDER 22 0.0030
350 TENDERNESS 31 0.0030
351 OBSTRUCTIVE AIRWAYS DISORDER 33 0.0030
352 HYPERTENSIVE CRISIS 33 0.0030
353 WEIGHT FLUCTUATION 31 0.0030
354 THERMAL BURN 21 0.0030
355 RETCHING 63 0.0030
356 PELVIC FRACTURE 23 0.0030
357 VISION BLURRED 404 0.0029
358 GASTRITIS 77 0.0029
359 OSTEONECROSIS 96 0.0029
360 INTERVERTEBRAL DISC DEGENERATION 27 0.0029
361 PELVIC PAIN 53 0.0029
362 CEREBRAL ISCHAEMIA 15 0.0029
363 DYSSTASIA 85 0.0029
364 CARDIOMYOPATHY 43 0.0029
365 VISUAL FIELD DEFECT 21 0.0029
366 JOINT EFFUSION 20 0.0029
367 DYSPNOEA EXERTIONAL 109 0.0029
368 IMMUNE SYSTEM DISORDER 38 0.0029
369 TOOTH INFECTION 38 0.0029
370 LIMB DISCOMFORT 89 0.0029
371 DIARRHOEA 1844 0.0029
372 PULMONARY THROMBOSIS 31 0.0028
373 MUSCLE TIGHTNESS 46 0.0028
374 ASTHENIA 1065 0.0028
375 CONSTIPATION 617 0.0028
376 INSOMNIA 753 0.0028
377 DRY SKIN 376 0.0028
378 INTERSTITIAL LUNG DISEASE 135 0.0028
379 BLOOD PRESSURE INCREASED 424 0.0028
380 MOVEMENT DISORDER 89 0.0028
381 GLOSSODYNIA 62 0.0028
382 BLOOD PRESSURE ABNORMAL 55 0.0028
383 DRY EYE 138 0.0028
384 GINGIVAL PAIN 22 0.0028
385 SKIN DISORDER 92 0.0028
386 SEPSIS 307 0.0027
387 LIVER DISORDER 122 0.0027
388 HAEMATOTOXICITY 26 0.0027
389 NEUTROPHIL COUNT INCREASED 28 0.0027
390 ASTHENOPIA 15 0.0027
391 RETINAL DETACHMENT 25 0.0027
392 PURPURA 24 0.0027
393 SWELLING OF EYELID 17 0.0027
394 GAMMA-GLUTAMYLTRANSFERASE INCREASED 60 0.0027
395 OSTEOMYELITIS 49 0.0027
396 CENTRAL NERVOUS SYSTEM LESION 37 0.0027
397 FACIAL PAIN 24 0.0027
398 HICCUPS 22 0.0027
399 DYSGEUSIA 199 0.0027
400 DISEASE RECURRENCE 127 0.0027
401 TOOTH DISORDER 59 0.0027
402 ANAEMIA 506 0.0027
403 RENAL CYST 21 0.0026
404 LIGAMENT SPRAIN 26 0.0026
405 GLOMERULAR FILTRATION RATE DECREASED 32 0.0026
406 SPINAL FRACTURE 52 0.0026
407 BLOOD BILIRUBIN INCREASED 70 0.0026
408 BLOOD CREATININE INCREASED 169 0.0026
409 DRUG INTERACTION 409 0.0026
410 MOOD SWINGS 82 0.0026
411 HYPOPHOSPHATAEMIA 19 0.0026
412 PAIN IN EXTREMITY 757 0.0026
413 OESOPHAGITIS 28 0.0026
414 IMPAIRED HEALING 84 0.0026
415 SKIN FISSURES 50 0.0026
416 ANAL INCONTINENCE 23 0.0026
417 DISCOMFORT 156 0.0026
418 TOOTH ABSCESS 26 0.0026
419 SKIN LESION 70 0.0025
420 ARTERIOSCLEROSIS 24 0.0025
421 ABDOMINAL PAIN UPPER 522 0.0025
422 DENTAL CARIES 28 0.0025
423 LIVER FUNCTION TEST ABNORMAL 73 0.0025
424 APHONIA 35 0.0025
425 MEMORY IMPAIRMENT 344 0.0025
426 DRY MOUTH 203 0.0025
427 OROPHARYNGEAL PAIN 231 0.0025
428 VASCULITIS 29 0.0025
429 BLOOD TESTOSTERONE DECREASED 17 0.0025
430 INFARCTION 17 0.0025
431 ECCHYMOSIS 17 0.0025
432 RESPIRATORY RATE INCREASED 22 0.0025
433 ABDOMINAL PAIN 576 0.0025
434 LABORATORY TEST ABNORMAL 73 0.0025
435 POOR QUALITY SLEEP 53 0.0025
436 NAUSEA 1947 0.0025
437 ATRIOVENTRICULAR BLOCK 19 0.0025
438 PHARYNGEAL SWELLING 24 0.0025
439 EPISTAXIS 183 0.0024
440 SCIATICA 39 0.0024
441 UVEITIS 33 0.0024
442 THROMBOCYTOPENIA 272 0.0024
443 HYPERLIPIDAEMIA 29 0.0024
444 ABDOMINAL DISCOMFORT 407 0.0024
445 FEAR 65 0.0024
446 EMBOLISM 20 0.0024
447 SPINAL OSTEOARTHRITIS 21 0.0024
448 OSTEOARTHRITIS 101 0.0024
449 LACTIC ACIDOSIS 77 0.0024
450 TENDON PAIN 18 0.0024
451 PERIPHERAL SWELLING 366 0.0024
452 BREAST CANCER STAGE I 22 0.0024
453 FOOT FRACTURE 45 0.0024
454 SOMNOLENCE 476 0.0024
455 GAIT INABILITY 79 0.0024
456 MICTURITION URGENCY 27 0.0024
457 CELLULITIS 119 0.0024
458 MYELOSUPPRESSION 85 0.0024
459 CHOKING 46 0.0024
460 WRIST FRACTURE 28 0.0023
461 RIB FRACTURE 48 0.0023
462 PRODUCT DOSE OMISSION IN ERROR 66 0.0023
463 DYSPEPSIA 229 0.0023
464 SKELETAL INJURY 24 0.0023
465 LUPUS-LIKE SYNDROME 21 0.0023
466 MYOPATHY 20 0.0023
467 EYE DISCHARGE 24 0.0023
468 PSYCHIATRIC SYMPTOM 17 0.0023
469 INCREASED APPETITE 44 0.0023
470 PAIN OF SKIN 62 0.0023
471 SLEEP DISORDER 162 0.0023
472 ACUTE RESPIRATORY FAILURE 44 0.0023
473 BACK PAIN 530 0.0023
474 SKIN EXFOLIATION 192 0.0023
475 UPPER RESPIRATORY TRACT INFECTION 105 0.0023
476 PAPULE 16 0.0023
477 JAUNDICE 61 0.0023
478 THIRST 40 0.0022
479 QUALITY OF LIFE DECREASED 30 0.0022
480 CYSTITIS 71 0.0022
481 HUNGER 31 0.0022
482 NOCTURIA 27 0.0022
483 MUSCLE DISORDER 18 0.0022
484 DRUG RESISTANCE 57 0.0022
485 SKIN HYPERPIGMENTATION 19 0.0022
486 VOMITING 1038 0.0022
487 NIGHT SWEATS 71 0.0022
488 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 21 0.0022
489 PRODUCTIVE COUGH 105 0.0022
490 DERMATITIS 46 0.0022
491 PRURITUS 839 0.0022
492 RHINORRHOEA 141 0.0022
493 RASH PRURITIC 118 0.0022
494 SPINAL COMPRESSION FRACTURE 18 0.0022
495 PHARYNGITIS 27 0.0022
496 GASTROOESOPHAGEAL REFLUX DISEASE 175 0.0022
497 GAIT DISTURBANCE 415 0.0022
498 FAECES DISCOLOURED 47 0.0022
499 PRODUCT ADMINISTRATION INTERRUPTED 17 0.0022
500 FEMUR FRACTURE 67 0.0022
501 SUBARACHNOID HAEMORRHAGE 22 0.0022
502 GRIP STRENGTH DECREASED 19 0.0022
503 SECRETION DISCHARGE 27 0.0022
504 HYPOPHAGIA 55 0.0021
505 BURNING SENSATION 150 0.0021
506 SKIN PLAQUE 18 0.0021
507 DIZZINESS 1060 0.0021
508 VENTRICULAR EXTRASYSTOLES 22 0.0021
509 ILLNESS 218 0.0021
510 VISUAL IMPAIRMENT 262 0.0021
511 SENSORY LOSS 17 0.0021
512 BLOOD IRON DECREASED 25 0.0021
513 FLATULENCE 119 0.0021
514 BLOOD TRIGLYCERIDES INCREASED 37 0.0021
515 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
516 BLOOD MAGNESIUM DECREASED 18 0.0021
517 HYPOMAGNESAEMIA 29 0.0021
518 LIVER INJURY 51 0.0021
519 FALL 691 0.0021
520 FOOT DEFORMITY 23 0.0021
521 BONE MARROW FAILURE 42 0.0021
522 MALAISE 906 0.0021
523 DYSURIA 76 0.0021
524 FAECES SOFT 15 0.0021
525 HYPERGLYCAEMIA 75 0.0021
526 DYSPHONIA 120 0.0020
527 THERAPY PARTIAL RESPONDER 32 0.0020
528 GROIN PAIN 18 0.0020
529 PRODUCT SUBSTITUTION ISSUE 118 0.0020
530 ACUTE HEPATIC FAILURE 28 0.0020
531 AFFECTIVE DISORDER 16 0.0020
532 HEPATOMEGALY 20 0.0020
533 NERVOUSNESS 106 0.0020
534 BLOOD POTASSIUM DECREASED 61 0.0020
535 WEIGHT DECREASED 566 0.0020
536 ERUCTATION 39 0.0020
537 THROMBOSIS 162 0.0020
538 PETECHIAE 21 0.0020
539 HYPOCALCAEMIA 38 0.0020
540 DEPRESSION 455 0.0020
541 RED BLOOD CELL SEDIMENTATION RATE INCREASED 22 0.0020
542 THROAT IRRITATION 89 0.0020
543 URINARY TRACT INFECTION 338 0.0020
544 MUSCULOSKELETAL STIFFNESS 173 0.0020
545 BLOOD CHOLESTEROL INCREASED 92 0.0020
546 DYSPNOEA 1116 0.0020
547 EXOSTOSIS 18 0.0020
548 BLOOD UREA INCREASED 33 0.0020
549 HYSTERECTOMY 17 0.0020
550 SKIN SWELLING 17 0.0020
551 INCREASED TENDENCY TO BRUISE 18 0.0020
552 SWOLLEN TONGUE 61 0.0020
553 BLOOD PRESSURE SYSTOLIC INCREASED 38 0.0019
554 DECREASED ACTIVITY 21 0.0019
555 RASH MACULAR 68 0.0019
556 ABDOMINAL DISTENSION 203 0.0019
557 BLOOD CALCIUM INCREASED 17 0.0019
558 HEADACHE 1212 0.0019
559 POOR VENOUS ACCESS 20 0.0019
560 BONE LOSS 29 0.0019
561 HYPOKINESIA 28 0.0019
562 HIP FRACTURE 62 0.0019
563 PARAESTHESIA 303 0.0019
564 DYSPHAGIA 182 0.0019
565 EYE DISORDER 63 0.0019
566 ELECTROCARDIOGRAM ABNORMAL 15 0.0019
567 DEHYDRATION 255 0.0019
568 GINGIVAL BLEEDING 26 0.0019
569 EAR PAIN 37 0.0019
570 INFLAMMATION 98 0.0019
571 EPILEPSY 58 0.0019
572 SCRATCH 20 0.0019
573 MUSCLE ATROPHY 24 0.0019
574 COVID-19 332 0.0019
575 CHOLELITHIASIS 62 0.0019
576 CATARACT 112 0.0019
577 VENTRICULAR TACHYCARDIA 31 0.0019
578 CARDIOMEGALY 23 0.0019
579 NASOPHARYNGITIS 343 0.0019
580 HYPOAESTHESIA ORAL 28 0.0019
581 RENAL IMPAIRMENT 156 0.0019
582 DIZZINESS POSTURAL 18 0.0019
583 PYREXIA 642 0.0019
584 BACTERAEMIA 22 0.0019
585 MUSCLE STRAIN 16 0.0018
586 BALANCE DISORDER 159 0.0018
587 ASPHYXIA 15 0.0018
588 SEASONAL ALLERGY 26 0.0018
589 ACUTE KIDNEY INJURY 281 0.0018
590 MYOCARDITIS 21 0.0018
591 INFLUENZA 204 0.0018
592 NEUROTOXICITY 32 0.0018
593 HYPERAESTHESIA 15 0.0018
594 JOINT INJURY 39 0.0018
595 MUSCLE SPASMS 335 0.0018
596 HYPOAESTHESIA 273 0.0018
597 POLLAKIURIA 76 0.0018
598 VERTIGO 111 0.0018
599 ABDOMINAL PAIN LOWER 46 0.0018
600 TUBULOINTERSTITIAL NEPHRITIS 34 0.0018
601 NEOPLASM MALIGNANT 121 0.0018
602 ARTHRITIS 142 0.0018
603 PARAESTHESIA ORAL 26 0.0018
604 ANXIETY 512 0.0018
605 BLISTER 100 0.0018
606 COGNITIVE DISORDER 83 0.0018
607 HYPONATRAEMIA 100 0.0018
608 ARRHYTHMIA 84 0.0018
609 VIRAL INFECTION 59 0.0018
610 IRRITABLE BOWEL SYNDROME 38 0.0018
611 PANCYTOPENIA 99 0.0018
612 HEPATOCELLULAR INJURY 25 0.0018
613 OPTIC NEURITIS 16 0.0018
614 HYPERCHOLESTEROLAEMIA 17 0.0018
615 MACULAR DEGENERATION 21 0.0018
616 DRUG LEVEL INCREASED 29 0.0018
617 DERMATITIS ALLERGIC 22 0.0017
618 ANKLE FRACTURE 27 0.0017
619 CARDIAC FAILURE 140 0.0017
620 PAIN 1071 0.0017
621 HEAD INJURY 55 0.0017
622 ANAPHYLACTIC REACTION 96 0.0017
623 HYPOKALAEMIA 80 0.0017
624 PULMONARY HYPERTENSION 36 0.0017
625 PULMONARY EMBOLISM 164 0.0017
626 PRODUCT DISTRIBUTION ISSUE 16 0.0017
627 DEAFNESS 45 0.0017
628 HYPOACUSIS 74 0.0017
629 APATHY 25 0.0017
630 MUSCULOSKELETAL PAIN 89 0.0017
631 LIMB INJURY 46 0.0017
632 ORAL HERPES 33 0.0017
633 TOXIC SKIN ERUPTION 17 0.0017
634 URINARY INCONTINENCE 50 0.0017
635 MOOD ALTERED 46 0.0017
636 CHEST PAIN 310 0.0017
637 HYPOGLYCAEMIA 81 0.0017
638 NASAL CONGESTION 98 0.0017
639 SINUS DISORDER 33 0.0017
640 FEELING HOT 102 0.0017
641 PHARYNGITIS STREPTOCOCCAL 18 0.0017
642 FEELING ABNORMAL 398 0.0017
643 HAEMATOMA 43 0.0017
644 HEPATIC ENZYME INCREASED 113 0.0017
645 ATELECTASIS 16 0.0017
646 CRYING 60 0.0016
647 LOWER RESPIRATORY TRACT INFECTION 75 0.0016
648 BURSITIS 20 0.0016
649 PERICARDIAL EFFUSION 38 0.0016
650 PNEUMOTHORAX 26 0.0016
651 BRAIN NEOPLASM 15 0.0016
652 RENAL TUBULAR NECROSIS 16 0.0016
653 HYPERTENSION 345 0.0016
654 NECK PAIN 91 0.0016
655 VITREOUS FLOATERS 16 0.0016
656 DEVICE RELATED INFECTION 25 0.0016
657 SWELLING 152 0.0016
658 CHRONIC KIDNEY DISEASE 123 0.0016
659 CONTUSION 155 0.0016
660 EMOTIONAL DISTRESS 194 0.0016
661 OVARIAN CYST 16 0.0016
662 GENERAL PHYSICAL HEALTH DETERIORATION 185 0.0016
663 EMOTIONAL DISORDER 49 0.0016
664 MYOCARDIAL ISCHAEMIA 18 0.0016
665 HYPOTHERMIA 16 0.0016
666 HYPERSENSITIVITY 293 0.0016
667 DIABETES MELLITUS 120 0.0016
668 WEIGHT INCREASED 352 0.0016
669 ULCER 25 0.0016
670 SKIN LACERATION 17 0.0016
671 MUSCLE TWITCHING 36 0.0016
672 SKIN REACTION 22 0.0016
673 MOBILITY DECREASED 112 0.0016
674 GLAUCOMA 30 0.0016
675 LYMPHOPENIA 22 0.0016
676 GASTROENTERITIS VIRAL 28 0.0015
677 RECTAL HAEMORRHAGE 66 0.0015
678 LUNG DISORDER 75 0.0015
679 PRODUCT ODOUR ABNORMAL 16 0.0015
680 HEPATITIS 39 0.0015
681 FIBROMYALGIA 37 0.0015
682 SCAR 26 0.0015
683 FREQUENT BOWEL MOVEMENTS 41 0.0015
684 HERPES ZOSTER 87 0.0015
685 ARTHROPATHY 84 0.0015
686 SPEECH DISORDER 79 0.0015
687 GLYCOSYLATED HAEMOGLOBIN INCREASED 38 0.0015
688 HYPERSOMNIA 43 0.0015
689 ATRIAL FIBRILLATION 146 0.0015
690 FLUID RETENTION 76 0.0015
691 MUSCULAR WEAKNESS 169 0.0015
692 GASTROINTESTINAL DISORDER 133 0.0015
693 SKIN HAEMORRHAGE 22 0.0015
694 SINUSITIS 152 0.0015
695 COLITIS 56 0.0015
696 BACK DISORDER 24 0.0015
697 PULMONARY OEDEMA 66 0.0015
698 FEELING COLD 41 0.0015
699 BODY TEMPERATURE INCREASED 30 0.0015
700 INTERVERTEBRAL DISC PROTRUSION 32 0.0015
701 PALPITATIONS 171 0.0015
702 RASH 635 0.0015
703 OEDEMA PERIPHERAL 177 0.0015
704 ANOSMIA 21 0.0014
705 PARANOIA 25 0.0014
706 BACTERIAL INFECTION 27 0.0014
707 TOOTH LOSS 30 0.0014
708 HEPATIC FUNCTION ABNORMAL 54 0.0014
709 DIVERTICULITIS 40 0.0014
710 NERVOUS SYSTEM DISORDER 45 0.0014
711 RASH MACULO-PAPULAR 32 0.0014
712 HYPERHIDROSIS 185 0.0014
713 HAEMOPTYSIS 40 0.0014
714 WHITE BLOOD CELL COUNT INCREASED 55 0.0014
715 EYE PRURITUS 48 0.0014
716 HEPATIC FAILURE 43 0.0014
717 END STAGE RENAL DISEASE 26 0.0014
718 THERAPY CESSATION 73 0.0014
719 COLD SWEAT 25 0.0014
720 RESPIRATORY FAILURE 103 0.0014
721 PNEUMONIA 457 0.0014
722 PULMONARY FIBROSIS 27 0.0014
723 PRODUCT TASTE ABNORMAL 19 0.0014
724 ROTATOR CUFF SYNDROME 18 0.0014
725 BLOOD PRESSURE DECREASED 93 0.0014
726 THERAPY INTERRUPTED 100 0.0014
727 ILL-DEFINED DISORDER 85 0.0014
728 INTENTIONAL PRODUCT MISUSE 122 0.0014
729 SKIN ULCER 36 0.0014
730 DEVICE MECHANICAL ISSUE 19 0.0014
731 PRODUCT PRESCRIBING ERROR 33 0.0014
732 RENAL DISORDER 64 0.0014
733 CHROMATURIA 31 0.0014
734 AMNESIA 89 0.0014
735 PROTEINURIA 26 0.0014
736 SEXUAL DYSFUNCTION 16 0.0014
737 LOCALISED INFECTION 33 0.0014
738 IRRITABILITY 82 0.0014
739 SARS-COV-2 TEST POSITIVE 18 0.0014
740 INFECTION 197 0.0014
741 LETHARGY 78 0.0014
742 MENTAL DISORDER 59 0.0014
743 UPPER LIMB FRACTURE 27 0.0014
744 BLOOD POTASSIUM INCREASED 22 0.0014
745 DRUG ERUPTION 24 0.0014
746 CIRCULATORY COLLAPSE 23 0.0013
747 HYPOTHYROIDISM 43 0.0013
748 THINKING ABNORMAL 25 0.0013
749 SINUS CONGESTION 18 0.0013
750 BLOOD SODIUM DECREASED 25 0.0013
751 HALLUCINATION, VISUAL 28 0.0013
752 CARDIOGENIC SHOCK 19 0.0013
753 LIP SWELLING 44 0.0013
754 ABSCESS 21 0.0013
755 PERIPHERAL COLDNESS 18 0.0013
756 THYROID DISORDER 20 0.0013
757 TENDON RUPTURE 16 0.0013
758 ORAL DISCOMFORT 18 0.0013
759 PRODUCT USE ISSUE 243 0.0013
760 HERNIA 25 0.0013
761 JOINT SWELLING 156 0.0013
762 BLOOD PRESSURE FLUCTUATION 31 0.0013
763 ORAL CANDIDIASIS 17 0.0013
764 SWELLING FACE 84 0.0013
765 ADVERSE REACTION 17 0.0013
766 ERYTHEMA 262 0.0013
767 TRANSIENT ISCHAEMIC ATTACK 43 0.0013
768 EYE HAEMORRHAGE 17 0.0013
769 PRODUCT AVAILABILITY ISSUE 29 0.0013
770 MULTIPLE ORGAN DYSFUNCTION SYNDROME 36 0.0013
771 CHEST DISCOMFORT 130 0.0013
772 BLOOD URINE PRESENT 24 0.0013
773 ATAXIA 15 0.0013
774 ORTHOSTATIC HYPOTENSION 22 0.0013
775 LOCAL SWELLING 22 0.0013
776 FEBRILE NEUTROPENIA 83 0.0012
777 FACE OEDEMA 21 0.0012
778 CANDIDA INFECTION 21 0.0012
779 HEMIPARESIS 21 0.0012
780 PRODUCT PRESCRIBING ISSUE 27 0.0012
781 DEEP VEIN THROMBOSIS 80 0.0012
782 HYPERKALAEMIA 43 0.0012
783 APHASIA 37 0.0012
784 HEPATIC CIRRHOSIS 23 0.0012
785 LEUKOCYTOSIS 22 0.0012
786 CONFUSIONAL STATE 196 0.0012
787 PHOTOSENSITIVITY REACTION 20 0.0012
788 CYST 15 0.0012
789 BLINDNESS UNILATERAL 17 0.0012
790 SLEEP APNOEA SYNDROME 23 0.0012
791 HAEMORRHAGE INTRACRANIAL 18 0.0012
792 MIGRAINE 114 0.0012
793 CONDITION AGGRAVATED 363 0.0012
794 OXYGEN SATURATION DECREASED 67 0.0012
795 BLOOD GLUCOSE ABNORMAL 22 0.0012
796 CEREBRAL INFARCTION 29 0.0012
797 DIABETES MELLITUS INADEQUATE CONTROL 21 0.0012
798 DYSTONIA 23 0.0012
799 THROAT TIGHTNESS 32 0.0012
800 EYE SWELLING 44 0.0012
801 BONE DENSITY DECREASED 37 0.0012
802 BRONCHITIS 87 0.0012
803 RENAL FAILURE 156 0.0012
804 ADVERSE DRUG REACTION 105 0.0012
805 SNEEZING 26 0.0012
806 TREMOR 192 0.0012
807 PANCREATITIS ACUTE 26 0.0012
808 MENINGIOMA 18 0.0012
809 SEROTONIN SYNDROME 22 0.0011
810 BRADYCARDIA 60 0.0011
811 INFLUENZA LIKE ILLNESS 93 0.0011
812 EYE IRRITATION 65 0.0011
813 GALLBLADDER DISORDER 20 0.0011
814 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 19 0.0011
815 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 58 0.0011
816 URTICARIA 186 0.0011
817 URINARY RETENTION 37 0.0011
818 OEDEMA 60 0.0011
819 MUSCULOSKELETAL DISORDER 21 0.0011
820 PRODUCT DOSE OMISSION ISSUE 324 0.0011
821 GASTROENTERITIS 16 0.0011
822 OFF LABEL USE 958 0.0011
823 ACUTE MYOCARDIAL INFARCTION 32 0.0011
824 ANGINA PECTORIS 31 0.0011
825 WHEEZING 64 0.0011
826 PRODUCT USE COMPLAINT 17 0.0011
827 RHABDOMYOLYSIS 45 0.0011
828 COORDINATION ABNORMAL 15 0.0011
829 SURGERY 63 0.0011
830 C-REACTIVE PROTEIN INCREASED 39 0.0011
831 HALLUCINATION, AUDITORY 17 0.0011
832 NIGHTMARE 37 0.0011
833 PALLOR 29 0.0011
834 ANGER 36 0.0011
835 HEART RATE IRREGULAR 24 0.0011
836 DISORIENTATION 42 0.0011
837 SUICIDAL IDEATION 97 0.0011
838 OCULAR HYPERAEMIA 50 0.0011
839 NEPHROLITHIASIS 48 0.0010
840 RESTLESS LEGS SYNDROME 19 0.0010
841 RENAL INJURY 31 0.0010
842 POST PROCEDURAL COMPLICATION 20 0.0010
843 VISUAL ACUITY REDUCED 34 0.0010
844 HYPOXIA 36 0.0010
845 CYANOSIS 16 0.0010
846 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 183 0.0010
847 PANIC ATTACK 37 0.0010
848 ABNORMAL DREAMS 28 0.0010
849 SEIZURE 117 0.0010
850 RESPIRATORY TRACT CONGESTION 16 0.0010
851 OBESITY 16 0.0010
852 THERAPEUTIC RESPONSE UNEXPECTED 45 0.0010
853 DISTURBANCE IN ATTENTION 54 0.0010
854 GASTRIC ULCER 19 0.0010
855 PRODUCT ADMINISTRATION ERROR 20 0.0010
856 ANHEDONIA 26 0.0010
857 RESTLESSNESS 36 0.0010
858 DYSARTHRIA 37 0.0010
859 INTESTINAL OBSTRUCTION 37 0.0010
860 HEART RATE INCREASED 97 0.0010
861 EAR INFECTION 26 0.0010
862 PROCEDURAL PAIN 27 0.0010
863 HEART RATE DECREASED 34 0.0010
864 MIDDLE INSOMNIA 18 0.0010
865 BASAL CELL CARCINOMA 15 0.0010
866 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
867 HYPOTENSION 190 0.0009
868 RASH ERYTHEMATOUS 45 0.0009
869 SKIN IRRITATION 43 0.0009
870 ECZEMA 49 0.0009
871 DYSKINESIA 38 0.0009
872 BLOOD GLUCOSE INCREASED 175 0.0009
873 HAEMORRHAGE 97 0.0009
874 HAEMATOCHEZIA 51 0.0009
875 PRODUCT USE IN UNAPPROVED INDICATION 229 0.0009
876 DIABETIC KETOACIDOSIS 22 0.0009
877 AMENORRHOEA 16 0.0009
878 DISABILITY 18 0.0009
879 PRODUCT DOSE OMISSION 59 0.0009
880 HALLUCINATION 68 0.0009
881 VAGINAL HAEMORRHAGE 39 0.0009
882 TOXICITY TO VARIOUS AGENTS 151 0.0009
883 DELIRIUM 31 0.0009
884 GOUT 16 0.0009
885 IMPAIRED WORK ABILITY 19 0.0009
886 SKIN CANCER 19 0.0009
887 LUNG NEOPLASM MALIGNANT 36 0.0009
888 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 42 0.0009
889 CLOSTRIDIUM DIFFICILE INFECTION 19 0.0009
890 FUNGAL INFECTION 29 0.0009
891 CARDIAC FAILURE CONGESTIVE 69 0.0009
892 THERAPEUTIC RESPONSE DECREASED 52 0.0009
893 ERECTILE DYSFUNCTION 22 0.0009
894 KNEE ARTHROPLASTY 18 0.0009
895 MENTAL STATUS CHANGES 23 0.0008
896 INJURY 58 0.0008
897 ROAD TRAFFIC ACCIDENT 34 0.0008
898 ABNORMAL BEHAVIOUR 32 0.0008
899 CEREBROVASCULAR ACCIDENT 136 0.0008
900 GASTRIC DISORDER 27 0.0008
901 SHOCK 18 0.0008
902 LOSS OF CONSCIOUSNESS 100 0.0008
903 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 55 0.0008
904 MELAENA 17 0.0008
905 RASH GENERALISED 20 0.0008
906 TYPE 2 DIABETES MELLITUS 26 0.0008
907 INTENTIONAL PRODUCT USE ISSUE 67 0.0008
908 ASTHMA 86 0.0008
909 PRURITUS GENERALISED 16 0.0007
910 WITHDRAWAL SYNDROME 31 0.0007
911 INTENTIONAL DOSE OMISSION 21 0.0007
912 RESPIRATORY DISORDER 22 0.0007
913 PRODUCT DISPENSING ERROR 16 0.0007
914 ADVERSE EVENT 66 0.0007
915 DRUG INEFFECTIVE 942 0.0007
916 THERAPEUTIC PRODUCT EFFECT DECREASED 32 0.0007
917 ANGIOEDEMA 31 0.0007
918 EXPOSURE VIA SKIN CONTACT 18 0.0007
919 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
920 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
921 APPLICATION SITE PAIN 15 0.0007
922 STAPHYLOCOCCAL INFECTION 22 0.0007
923 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
924 HEPATIC CANCER 16 0.0007
925 UNEVALUABLE EVENT 50 0.0007
926 MENTAL IMPAIRMENT 16 0.0007
927 RENAL FAILURE ACUTE 28 0.0007
928 FLUSHING 67 0.0007
929 SKIN BURNING SENSATION 47 0.0007
930 ACCIDENTAL OVERDOSE 24 0.0007
931 RESPIRATORY TRACT INFECTION 17 0.0007
932 ABASIA 16 0.0006
933 DEVICE LEAKAGE 28 0.0006
934 BLOOD GLUCOSE DECREASED 31 0.0006
935 THERAPY NON-RESPONDER 29 0.0006
936 UNDERDOSE 46 0.0006
937 CONTRAINDICATED PRODUCT ADMINISTERED 19 0.0006
938 DEATH 538 0.0006
939 DEVICE BREAKAGE 25 0.0006
940 AGITATION 45 0.0006
941 CARDIAC DISORDER 57 0.0006
942 DEMENTIA 17 0.0006
943 INTENTIONAL OVERDOSE 39 0.0006
944 CARDIAC ARREST 50 0.0006
945 PSORIATIC ARTHROPATHY 24 0.0006
946 PLASMA CELL MYELOMA 23 0.0006
947 CEREBRAL HAEMORRHAGE 21 0.0006
948 GASTROINTESTINAL HAEMORRHAGE 49 0.0006
949 HOSPITALISATION 90 0.0006
950 RHEUMATOID ARTHRITIS 66 0.0006
951 SEPTIC SHOCK 25 0.0006
952 TREATMENT FAILURE 47 0.0006
953 TREATMENT NONCOMPLIANCE 31 0.0006
954 PSORIASIS 73 0.0006
955 DRUG ABUSE 46 0.0006
956 DRUG DOSE OMISSION BY DEVICE 43 0.0005
957 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 25 0.0005
958 SUICIDE ATTEMPT 32 0.0005
959 ACNE 40 0.0005
960 MYOCARDIAL INFARCTION 91 0.0005
961 INCORRECT DOSE ADMINISTERED 118 0.0005
962 INJECTION SITE MASS 19 0.0005
963 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 17 0.0005
964 INFUSION RELATED REACTION 32 0.0005
965 EXPIRED PRODUCT ADMINISTERED 16 0.0005
966 DRUG DOSE OMISSION 79 0.0005
967 DERMATITIS ATOPIC 25 0.0005
968 EXTRA DOSE ADMINISTERED 19 0.0005
969 DRUG EFFECT INCOMPLETE 17 0.0005
970 PRODUCT QUALITY ISSUE 62 0.0005
971 MULTIPLE SCLEROSIS RELAPSE 29 0.0004
972 AGGRESSION 21 0.0004
973 MULTIPLE SCLEROSIS 20 0.0004
974 PANCREATITIS 20 0.0004
975 INJECTION SITE PAIN 115 0.0004
976 INJECTION SITE SWELLING 28 0.0004
977 INJECTION SITE REACTION 25 0.0004
978 OVERDOSE 76 0.0004
979 ACCIDENTAL EXPOSURE TO PRODUCT 36 0.0003
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 69 0.0003
981 PRODUCT STORAGE ERROR 29 0.0003
982 DEVICE MALFUNCTION 23 0.0003
983 INJECTION SITE BRUISING 26 0.0003
984 DEVICE ISSUE 29 0.0003
985 INJECTION SITE PRURITUS 21 0.0003
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
987 MEDICATION ERROR 16 0.0003
988 DRUG EFFECT DECREASED 15 0.0003
989 INJECTION SITE HAEMORRHAGE 22 0.0003
990 INJECTION SITE ERYTHEMA 26 0.0002
991 NO ADVERSE EVENT 37 0.0002
992 DRUG WITHDRAWAL SYNDROME 17 0.0002